Qiang Zhou

机构：University of Electronic Science and Technology of China, Hunan Normal University, Shanghai University of Traditional Chinese Medicine, Sichuan Cancer Hospital, Yueyang Second People's Hospital, Yueyang Hospital · ORCID：0000-0003-4340-9781

发表论文 126 篇 · 总被引 3542 次 · h-index 32

代表论文

• Intratumoral PPT1-positive macrophages determine immunosuppressive contexture and immunotherapy response in hepatocellular carcinoma (2023 · Journal for ImmunoTherapy of Cancer · 被引 40)
• Functions of Key Enzymes of Glycolytic Metabolism in Tumor Microenvironment (2023 · Cellular Reprogramming · 被引 18)
• Artificial intelligence in tumor drug resistance: Mechanisms and treatment prospects (2025 · Intelligent Oncology · 被引 15)
• CDCA8 promotes bladder cancer survival by stabilizing HIF1α expression under hypoxia (2023 · Cell Death and Disease · 被引 11)
• FGFR2 fusion/rearrangement is associated with favorable prognosis and immunoactivation in patients with intrahepatic cholangiocarcinoma (2024 · The Oncologist · 被引 10)
• miR ‐199a/214 cluster enhances prostate cancer sensitiveness to nimotuzumab via targeting TBL1XR1 (2023 · The Kaohsiung Journal of Medical Sciences · 被引 8)